CAM
EXAS

Connacht Asset Management’s Exact Sciences EXAS Stock Holding History

Connacht Asset Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-6,006
Closed -$297K – 140
2022
Q4 		$297K Buy
+6,006
New +$245K 0.13% 103

Other funds holding EXAS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Connacht Asset Management's EXAS Position: Q1 2023 in Review

Connacht Asset Management sold out of Exact Sciences (EXAS) in Q1 2023, closing a stake of 6,006 shares — an estimated $297K sold.

Connacht Asset Management first reported a position in EXAS in Q4 2022 and held it in 1 quarter. The position peaked at $297K in Q4 2022. 584 funds tracked by Wall St. Rank hold EXAS as of Q1 2023.

  • Connacht Asset Management reported no remaining Exact Sciences position as of Q1 2023 after selling out during the quarter.
  • Connacht Asset Management sold 6,006 Exact Sciences shares in Q1 2023, an estimated $297K.
  • Connacht Asset Management first reported a position in Exact Sciences in Q4 2022 and held it in 1 quarter.
  • Connacht Asset Management's Exact Sciences position peaked at $297K in Q4 2022.
  • 584 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2023.

Based on Connacht Asset Management's 13F filing for Q1 2023, filed 15 May 2023.